Kingdom Financial Group’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
KCM
Kingdom Financial Group's BEAM Position: Q3 2026 in Review
Kingdom Financial Group held its Beam Therapeutics (BEAM) position steady in Q3 2026 at 1 share worth $19. The position accounts for ﹤0.01% of the portfolio, ranked #929.
Kingdom Financial Group first reported a position in BEAM in Q4 2025 and has held it in 4 quarters since. The position peaked at $27 in Q2 2026. 264 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.
- Kingdom Financial Group held 1 share of Beam Therapeutics worth $19 as of Q3 2026.
- Kingdom Financial Group left its Beam Therapeutics share count unchanged in Q3 2026.
- Beam Therapeutics made up ﹤0.01% of Kingdom Financial Group's portfolio in Q3 2026, its #929 holding.
- Kingdom Financial Group first reported a position in Beam Therapeutics in Q4 2025 and has held it in 4 quarters since.
- Kingdom Financial Group's Beam Therapeutics position peaked at $27 in Q2 2026.
- 264 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.
Based on Kingdom Financial Group's 13F filing for Q3 2026, filed 4 Nov 2026.